Starling Oncology

STLNNasdaq United States Health Care Medical/Nursing Services

Market cap

$670.608 M

$6.58 +4.44%

Close of 7 Oct 2026

As of 7 Oct 2026, Starling Oncology (STLN) has a market capitalization of $670.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$502.7M

#1898 by revenue

Earnings

$60.6B

#8 by earnings

Shares outstanding

101,916,115

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Other share classes

Starling Oncology lists more than one class of stock. Company figures above cover all classes combined.

STLNW

Medical/Nursing Services, ranked by market cap

All 29 →

#14Teladoc HealthTDOC$1.05B
#15AdaptHealthAHCO$786.7M
#16Starling OncologySTLN$670.6M
#17SBC Medical GroupSBC$548.2M
#18Strata Critical MedicalSRTA$420.2M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Starling Oncology, worth $78.5K. Grants and option exercises are excluded.

Jorey Chernett$78.5K
12,000 shares at $6.54 on 14 Aug 2026 · filed 17 Aug 2026

What if Starling Oncology were worth as much as…

Open the what-if tool →

Gold $28.8T

$282,481.67

Per share 42,930× higher

Bitcoin $1.67T

$16,388.46

Per share 2,491× higher

Nvidia $5.77T

$56,572.84

Per share 8,598× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Starling Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.